Summary
Boston Scientific Corporation (BSX) has filed an 8-K report on February 5, 2020, to announce its financial results for the fourth quarter and full year ended December 31, 2019. The company issued a press release on February 5, 2020, which is furnished as Exhibit 99.1 to this filing, detailing these results. Investors should refer to this press release for specific financial performance metrics, including revenue, profitability, and segment performance for the periods reported. While the 8-K itself does not contain the detailed financial data, it serves as the official notification and public release of the information. The press release (Exhibit 99.1) is the primary source for understanding Boston Scientific's operational and financial condition as of the end of 2019. It's important to note that the information furnished in Item 2.02 and Exhibit 99.1 is not considered "filed" under Section 18 of the Exchange Act, meaning the company is not subject to liability under that section for the content of this disclosure, nor is it automatically incorporated into other SEC filings.
Key Highlights
- 1Boston Scientific announced its Q4 and Full Year 2019 financial results via an 8-K filing on February 5, 2020.
- 2The detailed financial results are provided in a press release furnished as Exhibit 99.1.
- 3Investors should consult Exhibit 99.1 for specific performance data related to Q4 and Full Year 2019.
- 4The filing serves as an official notification of the company's financial performance disclosure.
- 5Information provided in Item 2.02 and Exhibit 99.1 is furnished, not filed, under Section 18 of the Exchange Act.
- 6The 8-K includes the Cover Page Interactive Data File (XBRL) for enhanced data analysis.